All sponsors

Jacobio Pharmaceuticals Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS7
PHASE 3 / 2-30
RECRUITING7
READOUTS ≤12 MONTHS3
READOUT SLIPPED >6 MO80%

Delay Index: of 5 active trials registered more than a year ago, 4 have moved their primary completion (readout) date by more than 6 months since first registration (median +12.0 months). See all sponsors →

Open Jacobio Pharmaceuticals Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
JAB-2485 (Aurora A inhibitor)
NCT05490472
P1/2RecruitingSolid Tumors; ER+ Breast Cancer1022026-08 (+24 mo)
JAB-23E73
NCT06959615
P1/2RecruitingAdvanced Solid Tumor3342026-12-31 (+12 mo)
JAB-30355
NCT06386146
P1/2RecruitingSolid Tumors1442027-01
JAB-8263
NCT07684157
P2RecruitingRheumatoid Arthritis (RA)322027-06-30
JAB-8263
NCT04686682
P1/2RecruitingNSCLC; SCLC1522028-01 (+72 mo)
JAB-23E73
NCT06973564
P1/2RecruitingAdvanced Solid Tumors3442028-11 (+12 mo)
JAB-23E73 tablet,nab-paclitaxel,gemcitabine
NCT07640295
P1/2RecruitingMetastatic Pancreatic Ductal Adenocarcinoma802029-12-31